India: Novartis Challenges Pro-health Patent Law
Swiss pharmaceutical company Novartis heads to the Indian Supreme Court today in New Delhi, in a final bid to undermine a key public health safeguard in Indian patent law specifically designed to prevent drug companies from abusive patenting practices which keep medicine prices high. If successful, the move would have a devastating impact on access … Read more